Skip to main content
TipRanks
Go Ultimate75% OFF

Mark Jason Heath Ellison Insider Profile

4 Followers

Mark Jason Heath Ellison, former CDO at Opiant Pharmaceuticals, holds 0.00 shares in Opiant Pharmaceuticals (Ticker: OPNT).

Mark Jason Heath Ellison's Trading History

OPNT
Opiant Pharmaceuticals
Mar 03, 2023―Uninformative Sell333.90K$0.00
OPNT
DateTransactionAmountNo. of SharesPrice per ShareProfitLink to Report
Mar 03, 2023Uninformative Sell$274.72K13,736$20.00―
Mar 03, 2023Uninformative Buy$0.002,000$0.00―
Mar 03, 2023Uninformative Sell$333.90K16,695$20.00―
Jan 31, 2023Informative Sell$12.36K610$20.26―
Jan 09, 2023Informative Sell$9.47K469$20.20―

You May Also Like

Mark Jason Heath Ellison insider profile FAQ

What stocks does Mark Jason Heath Ellison hold?
Mark Jason Heath Ellison holds: OPNT stocks.
What was Mark Jason Heath Ellison’s latest transaction?
Mark Jason Heath Ellison’s latest transaction was an Uninformative Sell of $333.90K.
What is Mark Jason Heath Ellison's role in Opiant Pharmaceuticals?
Mark Jason Heath Ellison's role in Opiant Pharmaceuticals is CDO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.